NAACCR Item #3930: Serum Albumin Pretreatment Level
| Item # | Length | Source of Standard | Section Name | Year Implemented | Version Implemented | XML NAACCR ID | Parent XML Element |
|---|---|---|---|---|---|---|---|
| 3930 | 1 | NAACCR | Stage/Prognostic Factors | 2018 | 18 | serumAlbuminPretreatmentLevel | Tumor |
Required Status:
NPCR Collect: No recommendation
CoC Collect: Required, site specific
SEER Collect: Required, site specific
CCCR Collect: Required, site specific; when available
Description
Albumin is the most abundant protein in human blood plasma. Serum albumin pretreatment level is a prognostic factor for plasma cell myeloma.
Rationale
Serum albumin pretreatment level is a prognostic factor required in AJCC 8th edition, Chapter 82 *Plasma Cell Myeloma and Plasma Cell Disorders*, for the Revised International Staging System (RISS).
Allowable Values
0, 1, 5, 7, 9
Codes
| Code | Description |
|---|---|
| 0 | Serum albumin <3.5 g/dL |
| 1 | Serum albumin =3.5 g/dL |
| 5 | Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 |
| 7 | Test ordered, results not in chart |
| 9 | Not documented in medical record Serum Albumin Pretreatment Level not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.